Development of Cognitive Assessment Tools in Parkinson Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Parkinson Disease
Interventions
DRUG

[123I] IBVM and SPECT imaging

Subjects will be injected with up to 4 mCi of 123-I IBVM followed by SPECT imaging.

DRUG

Subjects will undergo the 123-I IBVM imaging visit

Subjects will be injected with a bolus of up to 4 mCi of 123-I IBVM followed by serial SPECT imaging.

Trial Locations (1)

06510

Institute for Neurodegenerative Disorders, New Haven

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

University of Oklahoma

OTHER

lead

Institute for Neurodegenerative Disorders

OTHER

NCT00556764 - Development of Cognitive Assessment Tools in Parkinson Disease | Biotech Hunter | Biotech Hunter